DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

103 hedge funds and large institutions have $622M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 50 increasing their positions, 19 reducing their positions, and 13 closing their positions.

Holders
103
Holders Change
+8
Holders Change %
+8.42%
% of All Funds
2.3%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
22
Increased
50
Reduced
19
Closed
13
Calls
$133K
Puts
$1K
Net Calls
+$132K
Net Calls Change
+$122K

Top Buyers

1
BlackRock
1
BlackRock
New York
$46.3M
2
State Street
2
State Street
Massachusetts
$21.9M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$32.6M
4
RI
4
RTW Investments
New York
$63.1M
5
SCM
5
Sio Capital Management
New York
$4.74M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$26.3M
2
BM
2
Bridger Management
New York
$51M
3
EC
3
EcoR1 Capital
California
$35.5M
4
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$501K
5
MIM
5
Monashee Investment Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$95.5M – – –
RI
2
RTW Investments
New York
$63.1M +$4.77M +445,964 +8%
BM
3
Bridger Management
New York
$51M -$8.08M -756,310 -14%
BlackRock
4
BlackRock
New York
$46.3M +$14.6M +1,364,155 +46%
CAM
5
Cormorant Asset Management
Massachusetts
$37.2M -$804K -75,198 -2%
EC
6
EcoR1 Capital
California
$35.5M -$5.19M -485,920 -13%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$32.6M +$6.41M +600,000 +24%
RCM
8
RA Capital Management
Massachusetts
$26.3M -$15.8M -1,476,820 -38%
Vanguard Group
9
Vanguard Group
Pennsylvania
$25M +$3.82M +357,336 +18%
State Street
10
State Street
Massachusetts
$21.9M +$13.3M +1,247,187 +156%
Citadel Advisors
11
Citadel Advisors
Florida
$21.4M +$540K +50,504 +3%
GTC
12
Ghost Tree Capital
New York
$13.4M +$1.6M +150,000 +14%
Goldman Sachs
13
Goldman Sachs
New York
$13.2M -$1.33M -124,522 -9%
BI
14
BVF Inc
California
$13M +$680K +63,654 +6%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$11.8M -$91K -8,514 -0.8%
EA
16
Emerald Advisers
Pennsylvania
$10.8M +$403K +37,708 +4%
EMFAT
17
Emerald Mutual Fund Advisers Trust
Pennsylvania
$9.66M -$61.8K -5,781 -0.6%
UBS Group
18
UBS Group
Switzerland
$7.91M +$2.51M +234,497 +46%
Northern Trust
19
Northern Trust
Illinois
$6.92M +$947K +88,559 +16%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$5.93M +$1.17M +109,012 +24%
AG
21
Artal Group
Luxembourg
$5.61M +$1.07M +100,000 +24%
Deutsche Bank
22
Deutsche Bank
Germany
$5.4M +$1.5M +140,399 +38%
PAI
23
Palo Alto Investors
California
$5.36M – – –
CS
24
Candriam SCA
Luxembourg
$4.78M +$1.67M +156,000 +54%
SCM
25
Sio Capital Management
New York
$4.74M +$4.74M +443,409 New
1
2 3 4 5